Abstract
Treatment of HIV-infected patients with HAART has prolonged survival, and clinicians must now be concerned with chronic diseases, some of which may be more prevalent in this population. This article focuses on coronary heart disease in persons with HIV infection.
MeSH terms
-
Cholesterol, LDL / blood
-
Coronary Disease / complications*
-
Coronary Disease / epidemiology
-
Female
-
HIV Infections / complications*
-
HIV Infections / drug therapy
-
HIV Protease Inhibitors / therapeutic use
-
Humans
-
Hyperlipidemias / complications
-
Hyperlipidemias / drug therapy*
-
Hypolipidemic Agents / therapeutic use*
-
Incidence
-
Male
-
Patient Education as Topic
Substances
-
Cholesterol, LDL
-
HIV Protease Inhibitors
-
Hypolipidemic Agents